Literature DB >> 24143335

PURLs: should you still recommend omega-3 supplements?

Julie Monaco1, Anne Mounsey, Jennifer Bello Kottenstette.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24143335      PMCID： PMC3786657     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


× No keyword cloud information.
  9 in total

1.  Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease.

Authors:  Penny M Kris-Etherton; William S Harris; Lawrence J Appel
Journal:  Circulation       Date:  2002-11-19       Impact factor: 29.690

Review 2.  Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review.

Authors:  Lee Hooper; Rachel L Thompson; Roger A Harrison; Carolyn D Summerbell; Andy R Ness; Helen J Moore; Helen V Worthington; Paul N Durrington; Julian P T Higgins; Nigel E Capps; Rudolph A Riemersma; Shah B J Ebrahim; George Davey Smith
Journal:  BMJ       Date:  2006-03-24

3.  Fish oil in primary and secondary cardiovascular prevention.

Authors:  Surya M Artham; Carl J Lavie; Richard V Milani; Rishi G Anand; James H O'Keefe; Hector O Ventura
Journal:  Ochsner J       Date:  2008

4.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.

Authors: 
Journal:  Lancet       Date:  1999-08-07       Impact factor: 79.321

Review 5.  Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials.

Authors:  Sang Mi Kwak; Seung-Kwon Myung; Young Jae Lee; Hong Gwan Seo
Journal:  Arch Intern Med       Date:  2012-05-14

Review 6.  Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.

Authors:  Evangelos C Rizos; Evangelia E Ntzani; Eftychia Bika; Michael S Kostapanos; Moses S Elisaf
Journal:  JAMA       Date:  2012-09-12       Impact factor: 56.272

7.  Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.

Authors:  Mitsuhiro Yokoyama; Hideki Origasa; Masunori Matsuzaki; Yuji Matsuzawa; Yasushi Saito; Yuichi Ishikawa; Shinichi Oikawa; Jun Sasaki; Hitoshi Hishida; Hiroshige Itakura; Toru Kita; Akira Kitabatake; Noriaki Nakaya; Toshiie Sakata; Kazuyuki Shimada; Kunio Shirato
Journal:  Lancet       Date:  2007-03-31       Impact factor: 79.321

8.  Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial.

Authors:  Alejandro Macchia; Hugo Grancelli; Sergio Varini; Daniel Nul; Nicolás Laffaye; Javier Mariani; Daniel Ferrante; Raúl Badra; Julio Figal; Silvina Ramos; Gianni Tognoni; Hernán C Doval
Journal:  J Am Coll Cardiol       Date:  2012-12-19       Impact factor: 24.094

9.  Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.

Authors:  Frans Van de Werf; Jeroen Bax; Amadeo Betriu; Carina Blomstrom-Lundqvist; Filippo Crea; Volkmar Falk; Gerasimos Filippatos; Keith Fox; Kurt Huber; Adnan Kastrati; Annika Rosengren; P Gabriel Steg; Marco Tubaro; Freek Verheugt; Franz Weidinger; Michael Weis
Journal:  Eur Heart J       Date:  2008-11-12       Impact factor: 29.983
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.